CN Patent

CN101237873A — 用于治疗非小细胞肺癌的星形孢菌素衍生物

Assigned to Johannes Gutenberg Universitaet Mainz · Expires 2008-08-06 · 18y expired

What this patent protects

本发明涉及用FLT－3激酶抑制剂如PKC412治疗非小细胞肺癌的方法。本发明还涉及FLT－3激酶抑制剂和线粒体外膜透化作用的活化剂如BAK的活化剂的药物组合。本发明还涉及线粒体外膜透化作用的活化剂和FLT－3激酶抑制剂的药物组合用于治疗非小细胞肺癌的用途，以及此种药物组合物用于制备治疗非小细胞肺癌的药物的用途。

USPTO Abstract

本发明涉及用FLT－3激酶抑制剂如PKC412治疗非小细胞肺癌的方法。本发明还涉及FLT－3激酶抑制剂和线粒体外膜透化作用的活化剂如BAK的活化剂的药物组合。本发明还涉及线粒体外膜透化作用的活化剂和FLT－3激酶抑制剂的药物组合用于治疗非小细胞肺癌的用途，以及此种药物组合物用于制备治疗非小细胞肺癌的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101237873A
Jurisdiction
CN
Classification
—
Expires
2008-08-06
Drug substance claim
No
Drug product claim
No
Assignee
Johannes Gutenberg Universitaet Mainz
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.